NDC11 72606002506
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72606-0025-06 | 72606-0025 |
| 72606-0025-6 | 72606-0025 |
| 72606-025-06 | 72606-025 |
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 72606-025 | 72606-025-06 | I | Inactivated by FDA | 2026-08-03 |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZYMFENTRA | INFLIXIMAB-DYYB | CELLTRION USA Inc. | 93a193ab-9f96-4da6-aa7c-31212e81879a | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 72606-025-06 72606-025 72606002506 |